Sydney Seth, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 10606 Us Route 23, Lucasville, OH 45648 Phone: 740-259-0252 Fax: 740-259-0253 |
Mrs. Teresa Harrell, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 445 Eckhart Rd, Lucasville, OH 45648 Phone: 740-285-1044 |
Michael A. Lusk, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 10098 Bear Creek Rd, Lucasville, OH 45648 Phone: 740-259-5536 Fax: 740-259-2531 |
News Archive
Every fall, millions of people roll up their sleeves to get a flu shot. Up to 20 percent of the population gets the flu and more than 200,000 people are hospitalized with flu complications each year, according to the U.S. Centers for Disease Control and Prevention. While seasonal vaccines provide some protection, they are not always effective because the strains of influenza virus in the vaccine may not be well matched to the flu viruses circulating that year. So researchers are searching for a way to develop a more universal vaccine that would be effective against any variety of influenza.
A report issued by Thomson Reuters and shared in part at the Aspen Ideas Festival on July 10th, indicates that a combination of better coordinated public and private sector care; stronger patient awareness of health risks and wellness; and application of improved information systems to eliminate fraud and abuse could lead to a 50% reduction in wasteful spending in healthcare, saving 3.6 trillion dollars over the next decade.
TTP plc, a leading independent technology and product development company, today announced it has established a partnership with NHS Highland and The University of the Highlands and Islands, to use clinical data interpretation and machine learning algorithms to predict which patients with atrial fibrillation are able to be successfully treated using electrical cardioversion.
Heart failure patients with preserved ejection fraction (HFpEF) - where the heart becomes stiff and cannot relax or fill properly - did not have increased exercise tolerance after taking isosorbide mononitrate, compared to a placebo, according to a study presented today at the American Heart Association's Scientific Sessions 2015.
Using a discovery platform whose components range from yeast cells to human stem cells, Whitehead Institute scientists have identified a novel Parkinson's disease drug target and a compound capable of repairing neurons derived from Parkinson's patients.
› Verified 9 days ago